Benjamin Howard 4
4 · REPLIGEN CORP · Filed Dec 18, 2017
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
Benjamin Howard
Other
Transactions
- Exercise/Conversion
Common Stock
2017-12-14$15.91/sh+2,646$42,098→ 36,554 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-12-14−2,646→ 0 totalExercise: $15.91Exp: 2024-02-27→ Common Stock (2,646 underlying) - Exercise/Conversion
Common Stock
2017-12-14$26.20/sh+6,021$157,750→ 42,575 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-12-14−4,062→ 8,124 totalExercise: $26.05Exp: 2026-02-26→ Common Stock (4,062 underlying) - Sale
Common Stock
2017-12-14$35.34/sh−12,729$449,835→ 33,908 total - Exercise/Conversion
Common Stock
2017-12-14$26.05/sh+4,062$105,815→ 46,637 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-12-14−6,021→ 3,010 totalExercise: $26.20Exp: 2025-02-26→ Common Stock (6,021 underlying)
Footnotes (3)
- [F1]This option is currently exercisable.
- [F2]$35.3394 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.22 to $35.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date.